Totally agree also. This new product opens up so many questions. Such as why was it released in only CBD format and not THC. I'm assuming the answer is because they have parties that are interested in licensing the THC product. There are so many SKU possibilities with THC such as THC:CBD 1:1; 1:0 and 8:1 and then different SKUs for different strains White Widow 1:0; OG Kush 1:1; Indica; Sativa and on and on. First movers on this one are going to have a huge advantage. I think it's clear they're still pursuing the out-licensing format.
"Lexaria's ChrgD+ product format is being evaluated by others for use in their psychoactive cannabinoids products sector as per our proven track record as a technology provider to the industry."
I'm no longer bi-polar on this stock. ChargD+ is going to be a real disruptor. IMHO
News 
Market Data 
Discover 
